
LeMaitre Vascular (LMAT) Stock Forecast & Price Target
LeMaitre Vascular (LMAT) Analyst Ratings
Bulls say
LeMaitre Vascular is poised for continued success with strong growth and cash flow, an expanding product portfolio, and promising international expansion plans. With consistent double-digit growth, improved gross margins, and successful sales, the company has a strong financial position. Additionally, successful regulatory submissions and plans for larger deals indicate potential for further growth and market expansion in the vascular and cardiac surgery fields.
Bears say
LeMaitre Vascular is performing better than expected in terms of sales, with a 12% growth rate and strong adjusted EPS of $0.68. However, the company's profitability may be hindered by higher than expected operating expenses, as well as a significant amount of debt on their balance sheet at $169 million. Additionally, while their sales force has grown, there are still open positions to fill, which could impact their sales in the near future.
This aggregate rating is based on analysts' research of LeMaitre Vascular and is not a guaranteed prediction by Public.com or investment advice.
LeMaitre Vascular (LMAT) Analyst Forecast & Price Prediction
Start investing in LeMaitre Vascular (LMAT)
Order type
Buy in
Order amount
Est. shares
0 shares